Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
Phase 3
Not yet recruiting
- Conditions
- Chronic Traumatic EncephalopathyAlzheimer Disease
- Interventions
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- CereMark Pharma, LLC
- Target Recruit Count
- 230
- Registration Number
- NCT06254469
© Copyright 2025. All Rights Reserved by MedPath